MedTrace Logo

Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study

NCT06053203 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2025-07-02

No results posted yet for this study

Summary

The goal of this study is to evaluate the use of aspirin for the prevention of preeclampsia among moderate -to- high-risk pregnant women in tertiary care hospitals in Nigeria followed by a qualitative study to evaluate the barriers and facilitators of aspirin use in prenatal care for the prevention of preeclampsia in Nigeria. The main question\[s\] it aims to answer are:

1. Is Aspirin used for the prevention of preeclampsia among pregnant women in Nigeria?
2. What factors promote or prevent the utilization of Aspirin for preeclampsia prevention among pregnant women in Nigeria.

Conditions

  • Hypertensive Disorders of Pregnancy

Interventions

OTHER

Exposure of interest - Moderate or High-risk Preeclampsia

No intervention

Sponsors & Collaborators

  • University of Abuja Teaching Hospital

    collaborator OTHER

  • Aminu Kano Teaching Hospital

    collaborator OTHER

  • Murtala Muhammad Specialist Hospital

    collaborator OTHER

  • National Hospital, Abuja

    collaborator OTHER_GOV

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mark Huffman, MD MPH · Washington University School of Medicine

  • Dike Ojji, MBBS PhD · University of Abuja Teaching Hospital

  • Kathryn Lindley · Vanderbilt University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-03-31
Completion
2024-11-30

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06053203 on ClinicalTrials.gov